LordsMed, the global healthcare division of Lord’s Mark Industries, has launched its in-vitro diagnostics (IVD) manufacturing facility at Vasai near Mumbai. Spread over 20,000 sq ft area, the IVD manufacturing facility is equipped with state-of-the-art technologies and infrastructure of global standards and will manufacture a diversified range of IVD and point of care diagnostic solutions such as analysers, reagents for clinical biochemistry, haematology, serology, immunology, rapid testing kits (ICMR approved antigen kit) and lab consumables.

The manufacturing facility has the capability to facilitate 1.7 crore diagnostic tests a month including bio chemistry, haematology, serology, rapid test and urine strip tests. LordsMed has plans to further scale up the capacity by investing Rs33 crore more in future.

With this advanced IVD manufacturing facility, LordsMed plans to facilitate backward integration, reduce import dependence and build self-reliance in procurement as well as foray into the OEM (original equipment manufacturer) market. 

LordsMed is in talks with pharmaceutical companies for OEM opportunities and plans to explore more opportunities both in the domestic and international markets. The company aims to go for R&D collaborations for developing rapid test kits as well.

LordsMed has recently partnered with a Singapore-based diagnostics kit manufacturer Sensing Self to manufacture its diagnostics solutions. The full-fledged manufacturing for Sensing Self will begin soon after the completion of the due diligence process. LordsMed is also in discussion with a few prominent distributors in Africa to export IVD solutions to the key markets of that region.